PharVision Advisers’s Snap SNAP Stock Holding History

PharVision Advisers’s Portfolio SNAP Stock Details SNAP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$109K	Sell	23,753 -15,009	-39%	-$88.4K	1.11%	43
2025 Q4	$313K	Buy	+38,762	New	+$307K	0.16%	248
2025 Q2	–	Sell	-12,396	Closed	-$108K	–	417
2025 Q1	$108K	Buy	+12,396	New	+$129K	0.15%	245

Other funds holding SNAP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

ICM

Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's SNAP Position: Q1 2026 in Review

PharVision Advisers reduced its Snap (SNAP) stake by 39% in Q1 2026, selling an estimated $88.4K and leaving 23,753 shares worth $109K. The position accounts for 1.11% of the portfolio, ranked #43.

PharVision Advisers first reported a position in SNAP in Q1 2025 and has held it in 3 quarters since. The position peaked at $313K in Q4 2025. 544 funds tracked by Wall St. Rank hold SNAP as of Q1 2026.

PharVision Advisers held 23,753 shares of Snap worth $109K as of Q1 2026.
PharVision Advisers sold 15,009 Snap shares in Q1 2026, an estimated $88.4K.
Snap made up 1.11% of PharVision Advisers's portfolio in Q1 2026, its #43 holding.
PharVision Advisers first reported a position in Snap in Q1 2025 and has held it in 3 quarters since.
PharVision Advisers's Snap position peaked at $313K in Q4 2025.
544 funds tracked by Wall St. Rank held Snap as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.